Results 231 to 240 of about 53,623 (345)

Complete genome sequencing of Enterobacter ludwigii strain T977 revealed its great ability for starch degradation of Nicotiana tabacum L. Yunyan 97. [PDF]

BMC Microbiol
Hu L, Gao Q, Ji Y, Dong X, Zhu Q, Cheng T, Zhao L, Yang M, Zhen Zhai, Dai H, Liang T, Xue C.   +11 more
europepmc   +1 more source

Purification and Crystallization of Taka-amylase

, 1951
Shiro Akabori, Bunji Hagihara, Tokuji Ikenaka   +2 more
openalex   +2 more sources

Review Article: Novel Enzyme Therapy Design for Gluten Peptide Digestion Through Exopeptidase Supplementation

Alimentary Pharmacology &Therapeutics, Volume 61, Issue 7, Page 1123-1139, April 2025.
Exopeptidases are key for completing protein digestion, including proline‐rich peptides, and are mostly produced by enterocytes of the intestinal brush border membrane. In coeliac disease, chronic inflammation leads to reduced brush border exopeptidase activity, exacerbating peptide accumulation.
Erin R. Bonner, Werner Tschollar, Robert Anderson, Sulayman Mourabit   +3 more
wiley   +1 more source

Optimization of thermostable amylolytic enzyme production from Bacillus cereus isolated from a recreational warm spring via Box Behnken design and response surface methodology. [PDF]

Microb Cell Fact
Adetiloye OA, Solomon BO, Omolaiye JA, Betiku E.   +3 more
europepmc   +1 more source

Invited Commentary: Management of Low Colorectal/Coloanal Anastomotic Leak: Results of a French National Inter‐Groups Practice Survey

World Journal of Surgery, EarlyView.
Yasuhiro Ishiyama, Yasumitsu Hirano
wiley   +1 more source

When, which and how to switch: Navigating JAK inhibitors in myelofibrosis

British Journal of Haematology, EarlyView.
Navigating choice of JAK inhibitor (JAKi) therapy for patients with myelofibrosis who are JAKi‐naïve and for those who have previously been treated with a JAKi.
Jennifer O'Sullivan, Imran Omerdeen, Bethan Psaila   +2 more
wiley   +1 more source

Development of a Simple Protocol to Assess Glucose Release After In Vitro Digestion, Allowing Comparison of Starchy Foods. [PDF]

Food Sci Nutr
Montebugnoli T, Antonelli G, Chiarello E, Rivera NS, Camporesi G, Danesi F, Bordoni A.   +6 more
europepmc   +1 more source

A Phase I, First‐In‐Human Study of CBA‐1205, an Anti‐DLK1 Monoclonal Antibody, in Patients With Advanced Solid Tumors

Cancer Science, Volume 116, Issue 4, Page 1012-1022, April 2025.
We conducted a Phase I trial of CBA‐1205, a novel monoclonal antibody targeting DLK1, in advanced solid tumors, demonstrating safety and tolerability with no dose‐limiting toxicities. Preliminary efficacy was observed, with six patients achieving stable disease for over 6 months, and sDLK1 was identified as a potential biomarker associated with ...
Yuki Katsuya, Masafumi Ikeda, Takafumi Koyama, Jun Sato, Mao Okada, Nobuaki Matsubara, Chihiro Kondoh, Toru Mukohara, Kazuo Watanabe, Daisuke Kotani, Yoshimi Ogawa, Shose Taoka, Noboru Yamamoto   +12 more
wiley   +1 more source

Probing the function of C-terminal region of recombinant α-amylase BmaN1 from Bacillus megaterium NL3. [PDF]

Microbiol Spectr
Frima FK, Thufail MA, Madhani IN, Nafisah Z, Shofiyah SS, Ulpiyana A, Puspasari F, Aditama R, Ihsanawati I, Natalia D.   +9 more
europepmc   +1 more source

The Action of Streptococcal Amylase in relation to the Synthesis of an Amylosaccharide by Amylolytic Strains of Streptococcus pyogenes

, 1955
Nuala Crowley
openalex   +1 more source